-
公开(公告)号:US20240349771A1
公开(公告)日:2024-10-24
申请号:US18637077
申请日:2024-04-16
发明人: Nora Schneider , Jonas Hauser , Sean Deoni , Tamas Bartfai , Jonathan O'Regan
IPC分类号: A23L33/00 , A23L33/12 , A23L33/15 , A23L33/16 , A24B15/38 , A61K9/00 , A61K31/14 , A61K31/202 , A61K31/519 , A61K31/661 , A61K31/70 , A61K31/714 , A61K33/00 , A61K33/06 , A61K33/26 , A61K33/30 , A61K33/42 , A61K45/06 , A61P25/28
CPC分类号: A23L33/40 , A23L33/12 , A23L33/15 , A23L33/16 , A23L33/30 , A24B15/38 , A61K9/0095 , A61K31/14 , A61K31/202 , A61K31/519 , A61K31/661 , A61K31/70 , A61K31/714 , A61K33/00 , A61K33/06 , A61K33/26 , A61K33/30 , A61K33/42 , A61K45/06 , A61P25/28 , A23V2002/00 , A23V2200/322 , A23V2250/1564 , A23V2250/1578 , A23V2250/1588 , A23V2250/1592 , A23V2250/161 , A23V2250/1618 , A23V2250/1642 , A23V2250/1846 , A23V2250/185 , A23V2250/1852 , A23V2250/1862 , A23V2250/1886 , A23V2250/5424 , A23V2250/7056 , A23V2250/706
摘要: A synthetic nutritional composition containing a phospholipid and/or a metabolic precursor and/or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential, and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
-
公开(公告)号:US20240349770A1
公开(公告)日:2024-10-24
申请号:US18557902
申请日:2022-04-28
申请人: DSM IP Assets B.V.
发明人: Nikolay KHANZHIN , Pierre CHASSAGNE
IPC分类号: A23L33/00 , A23L33/12 , A23L33/125 , A23L33/155
CPC分类号: A23L33/40 , A23L33/12 , A23L33/125 , A23L33/155
摘要: Infant formulae with a very low level of arsenic are obtained by selecting the components of the infant formula very carefully. For manufacturing infant formulae that comprise less than 95 parts per billion (ppb) of arsenic, it is preferred to use human milk oligosaccharides (HMOs) that have been isolated from a fermentation brth without using activated carbon in the last purification step. The preferred HMO is 2′-O-fucosyllactose.
-
3.
公开(公告)号:US20240285690A1
公开(公告)日:2024-08-29
申请号:US18657395
申请日:2024-05-07
IPC分类号: A61K35/20 , A23L2/66 , A23L33/00 , A23L33/12 , A23L33/125 , A23L33/15 , A23L33/19 , A61K9/00 , A61K31/202 , A61K31/355 , A61K31/375 , A61K31/661
CPC分类号: A61K35/20 , A23L2/66 , A23L33/12 , A23L33/125 , A23L33/15 , A23L33/19 , A23L33/40 , A61K9/0056 , A61K9/0095 , A61K31/202 , A61K31/355 , A61K31/375 , A61K31/661 , A23V2002/00
摘要: A nutritional composition that includes a milk fat globule membrane component, at least one human milk oligosaccharide, and at least one additional component chosen from the group consisting of DHA, ARA, Vitamin E, Vitamin C, and sphingomyelin. The nutritional composition is in the form of a ready-to-drink composition, a food supplement, an extruded food bar, or a solid oral dosage form. The nutritional composition is typically administered or provided to adults, children, or infants through consumption.
-
公开(公告)号:US20240138461A1
公开(公告)日:2024-05-02
申请号:US17754927
申请日:2020-10-16
IPC分类号: A23L33/00 , A23L33/12 , A23L33/18 , A61K31/198 , A61P31/00
CPC分类号: A23L33/40 , A23L33/12 , A23L33/18 , A61K31/198 , A61P31/00
摘要: An infant formula for use in reducing the occurrence of, or preventing, an infection in an infant, wherein the infant formula is an extensively hydrolysed infant formula (eHF) or an amino acid-based infant formula (AAF), wherein the infant formula comprises protein, carbohydrate and fat, wherein the eHF comprises about 2.4 g or less protein per 100 kcal, or the AAF comprises about 2.9 g or less protein per 100 kcal, wherein the infant formula further comprises 2′-fucosyllactose (2′FL) and/or lacto-N-neotetraose (LNnT), and wherein about 30% or less by weight of the fat is medium chain triglycerides (MCTs).
-
公开(公告)号:US11957148B2
公开(公告)日:2024-04-16
申请号:US16061424
申请日:2016-12-15
IPC分类号: A61P31/04 , A23L33/00 , A23L33/12 , A23L33/135 , A23L33/19 , A23L33/195 , A61K31/702 , A61P31/12
CPC分类号: A23L33/40 , A23L33/135 , A61K31/702 , A61P31/04 , A61P31/12 , A23L33/12 , A23L33/19 , A23L33/195 , Y02A50/30 , A61K31/702 , A61K2300/00
摘要: The invention relates to a mixture of human milk oligosaccharides and composition comprising thereof, that consists essentially of: LNnT, LNT, 2′-FL, 3′-SL, 6′-SL and either DFL or 3-FL, preferably DFL, that can be useful for preventing and/or treating viral and/or bacterial infections in a human.
-
公开(公告)号:US20240082199A1
公开(公告)日:2024-03-14
申请号:US18518044
申请日:2023-11-22
发明人: Bernard Cuenoud , Mojgan Masoodi
IPC分类号: A61K31/21 , A23K20/158 , A23L33/12
CPC分类号: A61K31/21 , A23K20/158 , A23L33/12 , A23V2002/00
摘要: A composition comprising medium-chain triglycerides (MCTs) wherein the composition comprises (i) a MCT comprising three fatty acid moieties each with 8 carbon atoms (MCT-C8) and (ii) a MCT comprising three fatty acid moieties each with 10 carbon atoms (MCT-C10); wherein the ratio of MCT-C8 to MCT-C10 is from 10:90 to 90:10 (mol/mol) and wherein the combined amount of MCT-C8 and MCT-C10 make up at least 50 mol % of the MCTs in the composition.
-
公开(公告)号:US11896565B2
公开(公告)日:2024-02-13
申请号:US17557429
申请日:2021-12-21
发明人: Gary Millet
IPC分类号: A61K31/19 , A61K31/593 , A23L33/12 , A61P3/00 , A61K47/14 , A23L33/16 , A23L33/175 , A61K9/00 , A61K9/02 , A61K9/14 , A61K9/20 , A61K9/48 , A61K47/10
CPC分类号: A61K31/19 , A23L33/12 , A23L33/16 , A23L33/175 , A61K9/006 , A61K9/0019 , A61K9/0053 , A61K9/0095 , A61K9/02 , A61K9/14 , A61K9/145 , A61K9/2004 , A61K9/2013 , A61K9/4841 , A61K9/4858 , A61K47/10 , A61K47/14 , A61P3/00 , A23V2002/00 , A23V2200/30 , A23V2250/02 , A23V2250/1876 , A23V2250/1878 , A23V2250/1884 , A23V2002/00 , A23V2200/30 , A23V2250/06 , A23V2250/1578 , A23V2250/16 , A23V2250/161 , A23V2250/1614 , A23V2250/1878 , A23V2250/1884
摘要: Ketogenic compositions including a plurality of beta-hydroxybutyrate (BHB) salts are formulated to induce or sustain ketosis in a subject to which the ketogenic compositions are administered. The BHB mixed salt is formulated to provide a biologically balanced set of cationic electrolytes and avoid detrimental health effects associated with imbalanced electrolyte ratios. A ketogenic composition includes BHB salts selected from sodium, potassium, calcium, and magnesium salts. The BHB composition may also include transition metal cations (e.g., zinc or iron), one or more BHB-amino acid salts, one or more ketone precursors, supplements, or other compounds that cause a rise in blood ketone levels without adding more electrolytes to the bloodstream, a short-, medium-, or long-chain fatty acid source, vitamins, minerals, flavorants, or other excipients.
-
8.
公开(公告)号:US11849747B1
公开(公告)日:2023-12-26
申请号:US16910775
申请日:2020-06-24
CPC分类号: A23L33/40 , A23L33/12 , A23L33/125 , A23L33/15 , A23L33/19 , A23V2002/00
摘要: A nutritional composition, typically an infant enterically administered nutritional composition, that comprises a milk fat globule membrane component, at least one human milk oligosaccharide and one additional component or a plurality of additional components where the additional component or components include DHA, ARA, Vitamin E, Vitamin C, and sphingomyelin.
-
公开(公告)号:US20230404102A1
公开(公告)日:2023-12-21
申请号:US18035594
申请日:2021-11-12
发明人: Harold M. MCNAMARA , Shara TICKU , David HELLER , Corentin MOEVUS
IPC分类号: A23D9/04 , C11B1/10 , C11C3/00 , C11C1/00 , C11B7/00 , A23D9/007 , A23G1/36 , A21D2/16 , A23C20/02 , A23L25/10 , A23L33/00 , A23L33/12 , A23L33/145
CPC分类号: A23D9/04 , C11B1/10 , C11C3/003 , C11C1/002 , C11B7/0075 , A23D9/007 , A23G1/36 , A21D2/165 , A23C20/025 , A23L25/10 , A23L33/40 , A23L33/12 , A23L33/145
摘要: The present disclosure relates to a microbial oil and/or derivative thereof, wherein the oil is produced by an oleaginous yeast. The disclosure also relates to blended fat compositions comprising a vegetable oil and an edible microbial oil. The disclosure further relates edible microbial oils and derivatives, and to food products comprising an edible microbial oil and/or a derivative thereof, and/or a blended fat composition, and methods of producing such food products. The microbial oil may serve as vegetable oil alternatives and be processed and/or derivatized by any number of means known in the art.
-
公开(公告)号:US11834621B2
公开(公告)日:2023-12-05
申请号:US17150898
申请日:2021-01-15
申请人: Commonwealth Scientific and Industrial Research Organisation , Grains Research and Development Corporation , Nuseed Nutritional Australia Pty Ltd
IPC分类号: C11B1/10 , C07C67/02 , C11C3/00 , C12N9/10 , C12N15/82 , C07C57/03 , C07C57/02 , A01H5/10 , A01H6/20 , A01H1/00 , C11B1/00 , C11C3/06 , A61K36/31 , C11C1/00 , A23L33/12 , C07K14/415 , A23K20/158 , A61K31/231 , A61K31/232
CPC分类号: C11B1/10 , A01H1/104 , A01H5/10 , A01H6/20 , A61K36/31 , C07C57/02 , C07C57/03 , C07C67/02 , C11B1/00 , C11C1/002 , C11C3/00 , C11C3/003 , C11C3/06 , C12N9/1025 , C12N15/8247 , A23K20/158 , A23L33/12 , A23V2002/00 , A61K31/231 , A61K31/232 , A61K2236/35 , C07K14/415
摘要: The present invention relates to extracted plant lipid, comprising fatty acids in an esterified form.
-
-
-
-
-
-
-
-
-